Insulin resistance in polycystic ovary syndrome phenotypes and the vicious cycle model in its etiology
Szkodziak P., Szkodziak F., Trzeciak K., Woźniak S., Mlynarczyk M., Paszkowski T.
Retrospective Study on Type 2 Diabetes, published in Sci Rep (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Sci Rep (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 41315368
- PMCID
- PMC12663220
- DOI
- 10.1038/s41598-025-26718-2
- Citations
- 1
Abstract (original English)
Polycystic ovary syndrome (PCOS) is a multifactorial disorder driven by at least three pathophysiological components: hypothalamic, ovarian, and obesity-related mechanisms. Insulin resistance (IR) is a unifying feature. Reciprocal interactions among androgen excess, hyperinsulinemia, and reduced hepatic sex hormone-binding globulin production create a self‑sustaining "vicious cycle" that exacerbates PCOS manifestations, which vary in severity and define four clinical phenotypes. To evaluate insulin resistance across PCOS phenotypes A (HA + OD + PCOM), B (HA + OD), C (HA + PCOM), and D (OD + PCOM). A retrospective observational study (2018-2022) of 200 Caucasian women aged 18-36 diagnosed with PCOS according to the Rotterdam criteria. Insulin resistance was assessed using HOMA‑IR. Clinical and anthropometric variables, Free Androgen Index (FAI), and Ferriman‑Gallwey (mFG) scores were analyzed by phenotype. Insulin resistance was present in 57.5% of participants. HOMA‑IR showed no correlation with PCOS duration but differed significantly between phenotypes. Mean HOMA‑IR values exceeded reference thresholds in all phenotypes: A 3.59, B 2.59, C 2.05, D 2.73. Moderate to strong positive correlations were observed between HOMA‑IR and mean arterial pressure, pulse rate, and waist‑to‑hip ratio, indicating an association with cardiometabolic risk across phenotypes. Positive associations
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol